孕早期地塞米松治疗与成人工作记忆脑活动无关
本研究纳入18名孕早期暴露于地塞米松但无先天性肾上腺皮质增生症(CAH)的受试者(8名女性,平均年龄20.78岁)和40名对照(24名女性,平均年龄20.53岁),进行功能磁共振成像工作记忆任务。结果显示两组工作记忆相关脑活动无差异,但DEX组在语言工作记忆实验条件下反应更快。结论认为孕早期DEX治疗未导致成人期工作记忆相关脑活动改变。
要点
- 孕早期DEX暴露未改变成人工作记忆脑活动。
- DEX组在语言工作记忆任务中反应更快。
- 结果为CAH孕早期DEX治疗的风险获益评估提供依据。
核心结论
- 孕早期DEX治疗未导致成人期工作记忆相关脑活动改变。
研究设计与样本
- 研究纳入18名孕早期暴露于DEX但无CAH的受试者(8名女性,平均年龄20.78岁,SD 2.67)和40名对照(24名女性,平均年龄20.53岁,SD 2.64),来自单一研究机构。
- 受试者在3T扫描仪下进行语言和视觉空间工作记忆任务的功能磁共振成像。
主要发现
- 工作记忆表现期间未观察到脑活动差异。
- DEX治疗受试者在语言工作记忆任务的实验条件下反应更快。
临床怎么用
- 本研究结果可用于CAH背景下产前DEX治疗的风险获益评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Prenatal dexamethasone (DEX) treatment is sometimes used in pregnancies at risk for congenital adrenal hyperplasia (CAH) to prevent virilization in female fetuses with CAH. In boys and in fetuses not having CAH, there is no benefit of early DEX treatment and the risks of this therapy must be thoroughly investigated. High doses of prenatal glucocorticoid might alter the developmental trajectory of the brain into adulthood, even for CAH unaffected subjects treated with DEX for a short term during the first trimester. OBJECTIVE: The present study investigated brain activation during working memory performance in DEX-treated subjects compared with controls. DESIGN, SETTING, AND PARTICIPANTS: We tested 18 participants who were exposed to DEX during the first trimester of fetal life but did not have CAH (8 females; mean age 20.78 [standard deviation (SD), 2.67] years) and 40 control participants (24 females; mean age 20.53 [SD, 2.64]) from a single research institute. Participants underwent functional magnetic resonance imaging on a 3T scanner during a verbal and visuospatial working memory task. RESULTS: We did not observe any differences in brain activity during working memory performance. However, DEX-treated subjects responded faster during the experimental condition of the verbal WM task. CONCLUSIONS: First trimester DEX treatment did not seem to result in altered working memory-related brain activity at adult age. Our findings contribute to the risk-benefit assessment of prenatal DEX treatment in the context of CAH.
引用
- Van't Westeinde A, Zimmermann M, Messina V, et al. First Trimester DEX Treatment Is Not Associated with Altered Brain Activity During Working Memory Performance in Adults. J Clin Endocrinol Metab. 2020. PMID: 32869847. doi:10.1210/clinem/dgaa611
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。